TABLE 4 Hepatocellular Neoplasms with Evidence for Activation of the Wnt Signaling Pathway by Nuclear β-Catenin Immunostaining and for β-Catenin, APC, and Axin I Mutations
From: Hepatic Adenomas: Analysis of Sex Steroid Receptor Status and the Wnt Signaling Pathway
Neoplasm | Nuclear β-Catenin Staining, % (N) | Exon 3 β-Catenin Mutations, % (N) [breakdown] | APC Mutations, % (N) | Axin I Mutations, % (N) |
---|---|---|---|---|
Hepatoblastomaa | 78 (65) | 52 (177) [33% deletions, 19% point mutations] | 12 (168) | NA |
Hepatocellular carcinomab | 32 (684) | 17 (1183) [2% deletions, 15% point mutations] | 0 (68) | 7 (237) |
Hepatic adenoma | 47 (15) | 0 (15) | 0 (15) | NA |